 |
12 Diseases |  |
3 Trials |
|
3 Trials |  |
188 News |  |
| «123 |
- |||| NovoEight (turoctocog alfa) / Novo Nordisk
Trial primary completion date: Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A (clinicaltrials.gov) - Apr 21, 2017
P3, N=60, Active, not recruiting, Sponsor: Novo Nordisk A/S
Trial primary completion date: Jun 2018 --> Feb 2017
- |||||| NovoEight (turoctocog alfa) / Novo Nordisk
Enrollment open: guardian TM 7: Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (clinicaltrials.gov) - Dec 19, 2016
P3, N=65, Recruiting, Sponsor: Novo Nordisk A/S
Trial primary completion date: Jun 2018 --> Feb 2017 Not yet recruiting --> Recruiting
- | NovoEight (turoctocog alfa) / Novo Nordisk
New P1 trial: guardian (clinicaltrials.gov) - Oct 20, 2016
P1, N=35, Recruiting, Sponsor: Novo Nordisk A/S
- |||||||||| NovoEight (turoctocog alfa) / Novo Nordisk
New P3 trial: guardian TM 7: Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (clinicaltrials.gov) - Oct 18, 2016
P3, N=65, Not yet recruiting, Sponsor: Novo Nordisk A/S
- ||||||| NovoEight (turoctocog alfa) / Novo Nordisk
Trial completion: Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015 (clinicaltrials.gov) - Aug 1, 2016
P3, N=214, Completed, Sponsor: Novo Nordisk A/S
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||| NovoEight (turoctocog alfa) / Novo Nordisk
Enrollment closed: Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A (clinicaltrials.gov) - Jul 29, 2016
P3, N=60, Active, not recruiting, Sponsor: Novo Nordisk A/S
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||| Enrollment open: ATHN 2: Factor Switching Study (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=600, Recruiting, Sponsor: American Thrombosis and Hemostasis Network
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||| New trial: ATHN 2: Factor Switching Study (clinicaltrials.gov) - Sep 14, 2015
P=N/A, N=600, Not yet recruiting, Sponsor: American Thrombosis and Hemostasis Network
- NovoEight (turoctocog alfa) / Novo Nordisk
Enrollment status: guardian (clinicaltrials.gov) - Oct 17, 2014
P=N/A, N=70, Enrolling by invitation, Sponsor: Novo Nordisk A/S
Not yet recruiting --> Recruiting Recruiting --> Enrolling by invitation
- NovoEight (turoctocog alfa) / Novo Nordisk
Enrollment open: To Investigate Safety and Efficacy of NovoEight (clinicaltrials.gov) - Sep 15, 2014
P=N/A, N=35, Recruiting, Sponsor: Novo Nordisk A/S
Recruiting --> Enrolling by invitation Not yet recruiting --> Recruiting
- NovoEight (turoctocog alfa) / Novo Nordisk
Japan: To Investigate Safety and Efficacy of NovoEight (clinicaltrials.gov) - Aug 4, 2014
P=N/A, N=35, Not yet recruiting, Sponsor: Novo Nordisk A/S
- NovoEight (turoctocog alfa) / Novo Nordisk
Enrollment open: guardian (clinicaltrials.gov) - Jun 18, 2014
P=N/A, N=70, Recruiting, Sponsor: Novo Nordisk A/S
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | NovoEight (turoctocog alfa) / Novo Nordisk
Enrollment closed: Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015 (clinicaltrials.gov) - Apr 17, 2013
P3, N=214, Active, not recruiting, Sponsor: Novo Nordisk A/S
Not yet recruiting --> Recruiting Enrolling by invitation --> Active, not recruiting
- | NovoEight (turoctocog alfa) / Novo Nordisk
Trial completion: Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A (clinicaltrials.gov) - Apr 10, 2013
P1, N=15, Completed, Sponsor: Novo Nordisk
Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
- | NovoEight (turoctocog alfa) / Novo Nordisk
New P1 trial: Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A (clinicaltrials.gov) - Sep 24, 2012
P1, N=15, Completed, Sponsor: Novo Nordisk
- | NovoEight (turoctocog alfa) / Novo Nordisk
Enrollment open: Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A (clinicaltrials.gov) - Sep 17, 2012
P3, N=60, Recruiting, Sponsor: Novo Nordisk A/S
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | NovoEight (turoctocog alfa) / Novo Nordisk
Trial initiation date: Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A (clinicaltrials.gov) - Sep 11, 2012
P3, N=60, Recruiting, Sponsor: Novo Nordisk A/S
Not yet recruiting --> Recruiting Initiation date: Dec 2011 --> Sep 2012
- | NovoEight (turoctocog alfa) / Novo Nordisk
Enrollment change: Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A (clinicaltrials.gov) - Jul 29, 2012
P3, N=60, Recruiting, Sponsor: Novo Nordisk A/S
Initiation date: Dec 2011 --> Sep 2012 N=120 --> 60
- || NovoEight (turoctocog alfa) / Novo Nordisk
New P3 trial: Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A (clinicaltrials.gov) - Dec 14, 2011
P3, N=60, Recruiting, Sponsor: Novo Nordisk A/S
- ||||||| NovoEight (turoctocog alfa) / Novo Nordisk
Trial completion: guardian (clinicaltrials.gov) - Nov 22, 2011
P3, N=65, Completed, Sponsor: Novo Nordisk
N=120 --> 60 Active, not recruiting --> Completed
- NovoEight (turoctocog alfa) / Novo Nordisk
Trial completion: A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543 (clinicaltrials.gov) - Oct 3, 2011
P1, N=6, Completed, Sponsor: Novo Nordisk
Active, not recruiting --> Completed Recruiting --> Completed
- ||||||| NovoEight (turoctocog alfa) / Novo Nordisk
Trial completion: guardian (clinicaltrials.gov) - Sep 27, 2011
P3, N=150, Completed, Sponsor: Novo Nordisk
Recruiting --> Completed Active, not recruiting --> Completed
- NovoEight (turoctocog alfa) / Novo Nordisk
Enrollment change: A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A (clinicaltrials.gov) - Sep 25, 2011
P1, N=4, Completed, Sponsor: Novo Nordisk
Active, not recruiting --> Completed N=10 --> 4
- NovoEight (turoctocog alfa) / Novo Nordisk
Trial completion: A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A (clinicaltrials.gov) - Sep 25, 2011
P1, N=4, Completed, Sponsor: Novo Nordisk
N=10 --> 4 Recruiting --> Completed